Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

BMEDvsFHLCETF Comparison

ETF 1
BMED

iShares Health Innovation Active ETF

This fund is part of
Healthcare Technology
-0.16%
VS
ETF 2
FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of
US Health Care
-0.17%

iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. Fidelity MSCI Health Care Index ETF (FHLC) is part of the US Health Care segment. BMED's top 3 sector exposures are Healthcare and Non-Corporate. In contrast, FHLC's top sector exposures are Healthcare and Consumer Non-Cyclicals.Business Services,  BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.084% for FHLC. BMED is up 1.48% year-to-date (YTD) with +$4M in YTD flows. FHLC performs better with 6.57% YTD performance, and +$244M in YTD flows. Run a side-by-side ETF comparison of BMED and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

BMED vs FHLC performance and flow charts

Performance

-2024681012%Jun 16Jun 24Jul 1Jul 9Jul 16

Cumulative Flows

0 M10 M20 M30 M40 MJun 16Jun 24Jul 1Jul 9Jul 16

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/17/2026
1M3MYTD1Y3Y5Y
Perf.
BMED
FHLC
+7.90%+7.02%
+4.20%+11.37%
+1.48%+6.57%
+23.30%+25.04%
+23.27%+31.20%
+4.16%+31.25%
Flows
BMED
FHLC
-+$20M
-+$112M
+$4M+$244M
+$6M+$269M
+$4M-$452M
+$5M-$71M
Volatility and drawdown
3M1Y3Y5Y
Volatility
BMED
FHLC
+17.48%+17.69%
+15.99%+15.44%
+16.00%+14.35%
+17.71%+15.25%
Max drawdown
BMED
FHLC
-7.61%-4.21%
-14.71%-10.35%
-19.76%-16.88%
-33.96%-17.78%
Max drawdown duration
BMED
FHLC
65d32d
176d169d
237d435d
1586d762d
Trading data

Create an account to view trading data

Join for free
BMED
FHLC
Last sale
7/17/2026 at 1:30 PM
$30.65
$78.39
Previous close
07/16/2026
$30.80
$78.61
Consolidated volume
07/16/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

BMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
BMED
FHLC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/17/2026 at 1:30 PM
Live
Closed
BMED
FHLC
Last price
$30.65
$78.39
1D performance
-0.49%
-0.28%
AuM$11.03 M$3.27 B
E/R0.77%0.084%
Characteristics
BMED
FHLC
Management strategyActivePassive
ProvideriSharesFidelity
Benchmark-MSCI USA IMI Health Care 25/50 Index
N° of holdings51329
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 29, 2020October 21, 2013
ESGNoNo
Advertisement
Exposure

Countries

BMED
USA
83.2%
Other
16.8%
FHLC
USA
97%
Other
3%

Sectors

BMED
Healthcare
94.88%
Other
5.12%
FHLC
Healthcare
97.73%
Other
2.27%
Advertisement

Diversification

BMED

Total weight of top 15 holdings out of 15

57.26%
FHLC

Total weight of top 15 holdings out of 15

61.64%

Top 15 holdings

Data as of May 31, 2026
BMED
Gilead Sciences, Inc.
5.42%
Merck & Co., Inc.
5.17%
Johnson & Johnson
5.15%
Edwards Lifesciences Corp.
4.79%
BlackRock Cash Funds - Treasury
4.74%
Waters Corp.
3.84%
Biogen, Inc.
3.67%
Bruker Corp.
3.64%
Amgen, Inc.
3.41%
WuXi Biologics (Cayman), Inc.
3.13%
Charles River Laboratories International, Inc.
3.12%
Vertex Pharmaceuticals, Inc.
2.99%
Mettler-Toledo International, Inc.
2.80%
Danaher Corp.
2.77%
Moderna, Inc.
2.65%
FHLC
Eli Lilly & Co.
14.18%
Johnson & Johnson
8.71%
AbbVie, Inc.
6.05%
UnitedHealth Group, Inc.
5.43%
Merck & Co., Inc.
4.66%
Thermo Fisher Scientific, Inc.
2.87%
Amgen, Inc.
2.84%
Gilead Sciences, Inc.
2.65%
Intuitive Surgical, Inc.
2.35%
Abbott Laboratories
2.35%
Pfizer Inc.
2.33%
CVS Health Corp.
1.85%
Bristol Myers Squibb Co.
1.81%
Danaher Corp.
1.80%
Vertex Pharmaceuticals, Inc.
1.78%
Frequently asked questions about BMED and FHLC

How have the BMED and FHLC ETFs performed in 2026?

As of July 17, 2026, BMED is up 1.48% year-to-date (YTD), while FHLC has returned 6.57%. That puts FHLC better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or FHLC?

Year-to-date, the BMED ETF saw +$4M in flows, compared to +$244M for FHLC.

Which ETF is more volatile: BMED or FHLC?

Over the past year, BMED had a volatility of 15.99%, while FHLC experienced 15.44%.

Which ETF is bigger: BMED or FHLC?

As of July 17, 2026, BMED holds $11.03 M in assets under management (AUM), while FHLC manages $3.27 B.

What sectors do the BMED and FHLC ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.

What are the top holdings of the BMED ETF and FHLC ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and Johnson & Johnson. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: BMED or FHLC?

BMED holds 54 securities with 57.26% of its assets in the top 15. FHLC has 334 securities and a top 15 weight of 61.64%.

Advertisement
Advertisement
Advertisement
ETF Comparison Tool

Have you tried our ETF Compare tool?

Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.